0001628280-21-012225.txt : 20210615 0001628280-21-012225.hdr.sgml : 20210615 20210615100643 ACCESSION NUMBER: 0001628280-21-012225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210610 FILED AS OF DATE: 20210615 DATE AS OF CHANGE: 20210615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JACOB GARY S CENTRAL INDEX KEY: 0001266802 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 211017132 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiff Oncology, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Trovagene, Inc. DATE OF NAME CHANGE: 20130304 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 4 1 wf-form4_162376598346799.xml FORM 4 X0306 4 2021-06-10 0 0001213037 Cardiff Oncology, Inc. CRDF 0001266802 JACOB GARY S C/O CARDIFF ONCOLOGY, INC. 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 0 0 0 1 Former Director Stock Options 2.6 2021-06-10 4 J 0 28858 0 A 2021-06-10 2023-06-10 Common Stock 28858.0 76106 D Stock Options 447.84 2021-06-10 4 J 0 293 0 A 2023-06-10 Common Stock 293.0 76106 D Stock Options 316.08 2021-06-10 4 J 0 218 0 A 2014-12-11 2023-06-10 Common Stock 218.0 76106 D Stock Options 516.96 2021-06-10 4 J 0 223 0 A 2016-03-17 2023-06-10 Common Stock 223.0 76106 D Stock Options 372.96 2021-06-10 4 J 0 223 0 A 2017-01-04 2023-06-10 Common Stock 223.0 76106 D Stock Options 51.84 2021-06-10 4 J 0 530 0 A 2018-10-04 2023-06-10 Common Stock 530.0 76106 D Stock Options 21.6 2021-06-10 4 J 0 755 0 A 2019-01-23 2023-06-10 Common Stock 755.0 76106 D Stock Options 2.48 2021-06-10 4 J 0 44734 0 A 2020-06-20 2023-06-10 Common Stock 44734.0 76106 D In connection with the Reporting Person's departure from the Board of Directors, the Compensation Committee accelerated the vesting of 28,858 stock options to June 10, 2021 from June 17, 2021. In addition, the Compensation Committee extended the expiration date of the stock options to June 10, 2023. Expiration date of the stock options was extended to June 10, 2023. 8,805 of the stock options vest immediately. 4,077 of the stock options vest on each of 2/25/2015 and 2016 and 4,076 of the stock options vest on 2/25/2017. /s/ Gary Jacob 2021-06-15